Literature DB >> 9215149

p53 gene product expression in resected non-small cell carcinoma of the lung, with studies of concurrent cytological preparations and microwave antigen retrieval.

S Binks1, C A Clelland, J Ronan, J Bell.   

Abstract

AIM: To document the frequency and extent of p53 gene product expression in paraffin sections of resected non-small cell carcinoma of the lung and in cytological preparations of the same tumours; to determine the effect of microwave antigen retrieval on antigen detection.
METHODS: Representative paraffin sections of 50 non-small cell carcinomas were stained with an antibody to p53 gene product (DO-7) both with and without prior microwave antigen retrieval. Cytoblocks and cell smears obtained from 19 cases were similarly stained.
RESULTS: Using a histochemical scoring system (0-300) which takes into account staining intensity and extent, 78% (n = 39) of microwave pretreated paraffin sections and 52% (n = 26) of non-pretreated sections scored between 5 and 300; p = 0.001; 56% (n = 28) of microwave pretreated sections and only 2% (n = 1) of non-pretreated sections scored between 100 and 300 (p = 0.0001); 75% of direct smears of tumours and 80% of cytoblocks stained similarly to the paraffin sections of the resected specimens. No smears or cytoblocks stained positively when the sections of the resected specimen were negative.
CONCLUSIONS: As up to 78% of non-small cell lung carcinomas overexpress p53 gene product, this may prove to be a valuable diagnostic method in biopsy or cytological material when the morphological diagnosis is uncertain. Microwave antigen retrieval is effective on formalin fixed tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215149      PMCID: PMC499883          DOI: 10.1136/jcp.50.4.320

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

2.  Detection of p53 gene mutations in cytopathology and biopsy specimens from patients with lung cancer.

Authors:  I Murakami; Y Fujiwara; N Yamaoka; K Hiyama; S Ishioka; M Yamakido
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

3.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

4.  Low p53 protein expression in salivary gland tumours compared with lung carcinomas.

Authors:  Y Soini; D Kamel; K Nuorva; D P Lane; K Vähäkangas; P Pääkkö
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines.

Authors:  J Caamano; B Ruggeri; S Momiki; A Sickler; S Y Zhang; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.

Authors:  D C Quinlan; A G Davidson; C L Summers; H E Warden; H M Doshi
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

7.  Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

Authors:  K H Vähäkangas; J M Samet; R A Metcalf; J A Welsh; W P Bennett; D P Lane; C C Harris
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

8.  Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.

Authors:  P L Porter; A M Gown; S G Kramp; M D Coltrera
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

10.  The relationship of p53 immunostaining to survival in carcinoma of the lung.

Authors:  R McLaren; I Kuzu; M Dunnill; A Harris; D Lane; K C Gatter
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

View more
  1 in total

1.  Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.

Authors:  W Hilbe; S Dirnhofer; F Oberwasserlechner; W Eisterer; K Ammann; T Schmid; G Hilbe; J Thaler; E Wöll
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.